Zdrowie i gospodarka · 10/08/2010
FDA Clears Way for Nandrolone Decanoate Injection to be Used for New Drug Applications
The FDA has determined that DECA-DURABOLIN injection, 200 mg/mL, 1 mL, was not withdrawn from sale due to safety or effectiveness concerns, paving the way for the approval of abbreviated new drug applications for this formulation.
Source: Federal Register — Health and Human ServicesOpen original release →